Up to 500 jobs to be created at Pfizer’s new ‘state of the art’ Dublin plant

The company will invest €1.2 billion in the facility, which is expected to be completed by 2027

Pfizer announced its intent to invest more than €1.2 billion capital investment in its Grange Castle, Dublin . Pictured at the announcement was Taoiseach Micheál Martin; and Mike McDermott, Pfizer’s Chief Global Supply Officer. Picture: Naoise Culhane

Pfizer, the multinational pharma giant, has confirmed plans to invest €1.2 billion to build a new state-of-the-art biotech manufacturing facility at its Grange Castle site in Dublin.

As first reported by the Business Post in October, the US company said the project is at the advanced design phase, and construction will commence in 2024. The new facility is expected to be completed by 2027 and will lead to the creation of up to 500 jobs.